Structural changes in Tau, such as hyperphosphorylation, often lead to its aggregation and accumulation in the brain, a hallmark of various clinically, biochemically and morphologically diverse neurodegenerative disorders known as “tauopathies” [11,12]. This evidence concerns the gene MAPT and tauopathy.